Literature DB >> 26343533

6,6'-Bieckol protects insulinoma cells against high glucose-induced glucotoxicity by reducing oxidative stress and apoptosis.

Mi-Hwa Park1, Soo-Jin Heo2, Kil-Nam Kim3, Ginnae Ahn4, Pyo-Jam Park5, Sang-Ho Moon6, Byong-Tae Jeon6, Seung-Hong Lee7.   

Abstract

Pancreatic β cells are highly sensitive to oxidative stress, which might play an important role in β cell death in diabetes. The protective effect of 6,6'-bieckol, a phlorotannin polyphenol compound purified from Ecklonia cava, against high glucose-induced glucotoxicity was investigated in rat insulinoma cells. High glucose (30 mM) treatment induced the death of rat insulinoma cells, but treatment with 10 or 50 μg/mL 6,6'-bieckol significantly inhibited the high glucose-induced glucotoxicity. Furthermore, treatment with 6,6'-bieckol dose-dependently reduced the level of thiobarbituric acid reactive substances, generation of intracellular reactive oxygen species, and the level of nitric oxide, all of which were increased by high glucose concentration. In addition, 6,6'-bieckol protected rat insulinoma cells from apoptosis under high-glucose conditions. These effects were associated with increased expression of the anti-apoptotic protein Bcl-2 and reduced expression of the pro-apoptotic protein Bax. These findings indicate that 6,6'-bieckol could be used as a potential nutraceutical agent offering protection against the glucotoxicity caused by hyperglycemia-induced oxidative stress associated with diabetes.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  6,6′-bieckol; Apoptosis; High glucose; Oxidative stress; Rat insulinoma cells

Mesh:

Substances:

Year:  2015        PMID: 26343533     DOI: 10.1016/j.fitote.2015.08.014

Source DB:  PubMed          Journal:  Fitoterapia        ISSN: 0367-326X            Impact factor:   2.882


  7 in total

1.  ALA/LA ameliorates glucose toxicity on HK-2 cells by attenuating oxidative stress and apoptosis through the ROS/p38/TGF-β1 pathway.

Authors:  Mingxia Jiang; Haifen Zhang; Lijie Zhai; Bianliang Ye; Yin Cheng; Chengkai Zhai
Journal:  Lipids Health Dis       Date:  2017-11-16       Impact factor: 3.876

2.  A phlorotannin constituent of Ecklonia cava alleviates postprandial hyperglycemia in diabetic mice.

Authors:  Hyun-Ah Lee; Ji-Hyeok Lee; Ji-Sook Han
Journal:  Pharm Biol       Date:  2017-12       Impact factor: 3.503

Review 3.  Phlorotannins: Towards New Pharmacological Interventions for Diabetes Mellitus Type 2.

Authors:  Graciliana Lopes; Paula B Andrade; Patrícia Valentão
Journal:  Molecules       Date:  2016-12-30       Impact factor: 4.411

Review 4.  Potential Role of Seaweed Polyphenols in Cardiovascular-Associated Disorders.

Authors:  Manuel Gómez-Guzmán; Alba Rodríguez-Nogales; Francesca Algieri; Julio Gálvez
Journal:  Mar Drugs       Date:  2018-07-28       Impact factor: 5.118

Review 5.  Recent advances in pharmacological research on Ecklonia species: a review.

Authors:  Prashamsa Koirala; Hyun Ah Jung; Jae Sue Choi
Journal:  Arch Pharm Res       Date:  2017-08-24       Impact factor: 4.946

Review 6.  Seaweed Phenolics: From Extraction to Applications.

Authors:  João Cotas; Adriana Leandro; Pedro Monteiro; Diana Pacheco; Artur Figueirinha; Ana M M Gonçalves; Gabriela Jorge da Silva; Leonel Pereira
Journal:  Mar Drugs       Date:  2020-07-24       Impact factor: 5.118

Review 7.  Extraction and Nano-Sized Delivery Systems for Phlorotannins to Improve Its Bioavailability and Bioactivity.

Authors:  Tianjian Tong; Xiaoyang Liu; Chenxu Yu
Journal:  Mar Drugs       Date:  2021-11-05       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.